Stemedica Awarded U.S. Patent for Transgenic Therapeutic Stem CellsPR Newswire (press release)Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company which manufactures best-in-class allogeneic adult stem cells and stem cell factors… Continue reading
Stemedica Awarded U.S. Patent for Transgenic Therapeutic Stem CellsPR Newswire (press release)Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company which manufactures best-in-class allogeneic adult stem cells and stem cell factors… Continue reading
|
MDI Gurgaon’s Samaritans and NGO Gene Bandhu team-up for stem cell donation
Economic Times MDI’s Samaritans and Gene Bandhu, an initiative of Safe Blood Organisation have collaborated with a vision to minimise the time required for a person to find a stem cell match and also ensure a successful donation. The MoU will focus on a fellowship … |
|
MDI Gurgaon’s Samaritans and NGO Gene Bandhu team-up for stem cell donation
Economic Times MDI’s Samaritans and Gene Bandhu, an initiative of Safe Blood Organisation have collaborated with a vision to minimise the time required for a person to find a stem cell match and also ensure a successful donation. The MoU will focus on a fellowship … |
5newsonline.com |
Booneville Pastor And Stem Cell Donor Fighting For His Own Life
5newsonline.com BOONEVILLE (KFSM) — A Booneville man, who donated stem cells to save a leukemia patient, is now fighting for his own life. John Taylor is a youth pastor at Free Will Baptist in Booneville. “It is kind of a roller coaster ride,” Taylor said. In … |
|
UCI-Led Team Begins First Clinical Trial of Stem Cell-Based Retinitis …
Newswise (press release) Newswise — Irvine, Calif., Aug. 12, 2015 — Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI’s Gavin Herbert … |
|
UCI-Led Team Begins First Clinical Trial of Stem Cell-Based Retinitis …
Newswise (press release) Newswise — Irvine, Calif., Aug. 12, 2015 — Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported project director Dr. Henry Klassen of UCI’s Gavin Herbert … |